Why is Windlas Biotech falling/rising?

As of 21-Jul, Windlas Biotech Ltd is experiencing a decline in its stock price, currently at 916.90, which reflects a decrease of 10.05 or 1.08%. The stock has underperformed its sector by 0.76% today and has been on a consecutive downward trend for the last three days, resulting in a total drop of 2.97% during this period. While the stock has shown a positive return of 34.10% over the past year, it has faced challenges with a year-to-date decline of 11.28%. Additionally, the stock is trading at a premium compared to its peers, and despite a low debt-to-equity ratio and increasing institutional investor participation, the company's operating profit growth has been modest, which may contribute to investor concerns.
In the broader market context, Windlas Biotech's short-term performance has been relatively better than the benchmark Sensex, which has seen a slight decline of 0.06% over the past week. However, the stock's recent performance contrasts with the benchmark's positive year-to-date return of 5.20%. The falling investor participation, indicated by a significant drop in delivery volume, suggests a lack of confidence among retail investors, which could be influencing the stock's downward movement. Overall, while institutional investors are increasing their stakes, the stock's recent performance and the flat results reported in March may be causing hesitation among other investors.